ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Ember Therapeutics Inc (CE)

Ember Therapeutics Inc (CE) (EMBT)

0.000001
0.00
(0.00%)
Closed October 09 4:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.000001
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.000001 52 Week Range 0.0001
Previous Close
0.000001
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
130
Financial Volume
-
VWAP
-

EMBT Latest News

Thoma Cressey Bravo Completes Acquisition of Embarcadero Technologies and Announces Settlement in Principle of Stockholders' Lit

Embarcadero Technologies, Inc. (NASDAQ:EMBT), a leading provider of strategic data management solutions, and Thoma Cressey Bravo, Inc., a leading private equity investment firm...

Embarcadero Technologies, Inc. Stockholders Approve Merger with Thoma Cressey Bravo

Embarcadero Technologies, Inc. (NASDAQ:EMBT) today announced that Embarcadero?s stockholders have voted to adopt the merger agreement providing for the acquisition of...

Embarcadero Technologies, Inc. Announces Additional Information Relating to Proposed Merger with Affiliate of Thoma Cressey Brav

Embarcadero Technologies, Inc. (NASDAQ: EMBT) today announced that it is making available additional information to its stockholders relating to Embarcadero?s proposed merger...

Embarcadero Technologies, Inc. Announces NASDAQ Call for Review and Stay of NASDAQ Panel Decision, Late Filing Notification for

Embarcadero Technologies, Inc. (NASDAQ: EMBT) announced today that on May 10, 2007, the NASDAQ Listing and Hearing Review Council (the ?Listing Council?) called for review and...

Embarcadero Technologies, Inc. Announces Receipt of Extension of NASDAQ Deadline

Embarcadero Technologies, Inc. (NASDAQ: EMBT) today announced that a NASDAQ Listing Qualifications Panel (the ?Panel?) has granted an extension of the previously-disclosed...

Embarcadero Technologies Introduces Web-Based Reporting for Database Auditing

Embarcadero Technologies, Inc. (Nasdaq: EMBT) today introduced DSAuditor 4.1, a professional-grade database auditing tool that enables organizations to identify performance...

Chapman Capital Supports Embarcadero Sale Agreement

Advisor to Vote All Shares in Favor of TCB Transaction LOS ANGELES, April 6 /PRNewswire/ -- Chapman Capital L.L.C., investment advisor to two investment funds that together own 9.3% of...

Chapman Capital Supports Embarcadero Sale Agreement Advisor to Vote All Shares in Favor of TCB Transaction

LOS ANGELES, April 6 /PRNewswire/ -- Chapman Capital L.L.C., investment advisor to two investment funds that together own 9.3% of Embarcadero Technologies, Inc. (NASDAQ:EMBT); ("Embarcadero" or...

Embarcadero Technologies, Inc. to Be Acquired by Thoma Cressey Bravo in a Transaction Valued at Approximately $200 Million and A

Embarcadero Technologies, Inc. (NASDAQ:EMBT), a leading provider of strategic data management solutions, and Thoma Cressey Bravo, a leading private equity investment firm, today...

Embarcadero Technologies, Inc. Receives NASDAQ Notice of Non-Compliance

Embarcadero Technologies, Inc. (NASDAQ:EMBT) today announced that, as expected, on March 21, 2007, it received an additional notice of non-compliance from the Staff of The...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
4001.0E-61.0E-61.0E-61501.0E-6CS
12001.0E-61.0E-61.0E-61301.0E-6CS
26-9.9E-5-990.00010.00011.0E-6811.0E-6CS
52-9.9E-5-990.00010.00011.0E-6811.0E-6CS
156-0.000299-99.66666666670.00030.00031.0E-67720.00010407CS
260-0.129899-99.99923017710.12999.991.0E-651980.80425999CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AABVFAberdeen International Inc (PK)
$ 0.02672
(0.00%)
0
AABKFAareal Bank AG (PK)
$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
$ 0.0375
(0.00%)
0
AAALYAareal Bank AG (PK)
$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
$ 0.02672
(0.00%)
0
AABKFAareal Bank AG (PK)
$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
$ 0.0375
(0.00%)
0
AAALYAareal Bank AG (PK)
$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
$ 0.55
(0.00%)
0
NTDOYNintendo Co Ltd (PK)
$ 13.46
(0.00%)
1.54M
PHJMFPt Hanjaya Mandala Sampoema (PK)
$ 0.0436
(0.00%)
1.38M
BACHFBank of China Ltd (PK)
$ 0.47
(0.00%)
802k
CHGCYChugai Pharmaceutical Ltd (PK)
$ 23.33
(0.00%)
518.7k
ACGBFAgricultural Bank of China (PK)
$ 0.46
(0.00%)
496k

EMBT Discussion

View Posts
TradeSmart.ai TradeSmart.ai 4 years ago
How to wipe out your account in one day. $EMBT
๐Ÿ‘๏ธ0
NotThatGuy NotThatGuy 4 years ago
This is the shit Iโ€™m taking about. People are so dumb n lazy. This is why i donโ€™t fault @RobinhoodApp. @CNBC mentions Ember cold storage for vaccine and people rush to buy $EMBT bc the name is Ember Therapeutics, a defunk pinksheet. Stock up 5000%. @jimcramer we gota teach them. pic.twitter.com/4h3xwr1Lbv— Michael Edward (@MikeEdward_TTG) December 16, 2020

wow
๐Ÿ‘๏ธ0
Awl416 Awl416 4 years ago
Jus browse twitter - the usual suspects
๐Ÿ‘๏ธ0
PENNY DIPZ PENNY DIPZ 4 years ago
Short Squeezed on this one!! $EMBT
๐Ÿ‘๏ธ0
NotThatGuy NotThatGuy 4 years ago
up 1,000% today and no posts. What is going on?
๐Ÿ‘๏ธ0
adijas adijas 6 years ago
8k out friday ah about PR that never hit OTCM https://www.otcmarkets.com/filing/html?id=12934395&guid=t8oEU6UER5vtath

Ember Therapeutics Enters Into Agreement to Divest OP-1 Portfolio Program to Viscogliosi Brothers, LLC
Published 3:53 PM ET Thu, 16 Aug 2018 PR Newswire


NEW YORK, Aug. 16, 2018 /PRNewswire/ -- Ember Therapeutics, Inc., a clinical stage biopharmaceutical company focused on the clinical application of Bone Morphogenetic Protein-7 (BMP-7), announced today that it has entered into a letter of intent with Viscogliosi Brothers, LLC (VB), a private equity investment firm focused on developing innovative neuromusculoskeletal technologies, for the sale of its OP-1 product family and related assets, which includes OP-1 Implant, OP-1 Putty, Opgenra and Osigraft for use in orthopaedic bone applications.

Ember Therapeutics had acquired the exclusive, worldwide license to the BMP-7 and OP-1 portfolio and associated intellectual property from Stryker Corporation in 2014. The previously commercialized OP-1 product portfolio had at one point generated approximately $100M in annual revenues for Stryker and had been viewed as a formidable competitor to Medtronic's Infuse.

The transaction is expected to close in late Q3 or Q4 of this year and is subject to financing. "This transaction allows Ember to continue to focus on our exciting late stage osteoarthritis (OA) program which offers the potential of addressing the actual cause of this debilitating disease by regrowing cartilage in the knee. OP-1, a related product for bone, has an immense amount of potential as has been previously used in over 50,000 patients," stated Joseph Hernandez, Executive Chairman of Ember Therapeutics. "We are excited to be working with the Viscogliosi Brothers in their efforts to commercially relaunch these products."

"We believe bone repair and regeneration is the future of orthopaedic healthcare," stated Anthony G. Viscogliosi, principal of Viscogliosi Brothers, LLC. "VB is delighted to have access once again to the previously commercialized OP-1 product family formerly owned by Stryker Biotech. This is the second publicly announced step VB has taken in the direction of assembling what we believe will be the leading global portfolio of BMP technology for stimulating bone growth."

About Ember Therapeutics, Inc.

Ember Therapeutics, Inc. is a pharmaceutical company developing targeted therapies for pain, osteoarthritis, kidney fibrosis and other regenerative medicines. In particular, Ember Therapeutics, Inc. has two commercial stage products and a late stage Phase 3 ready assets. For more information, please visit www.embertx.com.

About Viscogliosi Brothers, LLC

Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony G. Viscogliosi in New York City, in 1999, Viscogliosi Brothers, LLC (VB), is a family office holding company specializing in venture capital, private equity and merchant banking in the neuro-musculoskeletal/orthopedic industry.

VB's vision is dedicated to improving healthcare and the quality of life for humanity by finding innovative orthopedic concepts and supporting them to become sustainable technologies that can be commercialized globally to lead the evolution in orthopedic standards of care.

To accomplish this vision, VB discovers technologies, creates products and develops, builds, operates and finances companies founded on innovative and "life changing" technologies. VB principals have participated in more than 300 transactions, have invested in more than 20 companies and have formed more than ten funds.

Companies and funds that VB participated in have generated more than $1.5 billion in exit proceeds for investors through 14 exits in the last 18 years. Through its portfolio companies VB has defined 7 new orthopedic industry categories and its investments have helped commercialize more than 75 medtech devices, including eleven number one orthopedic technologies in seven market leading businesses.

VB orthopedic portfolio companies' products have been implanted in nearly 300,000 people in more than 70 countries globally.

For more information, please visit www.vbllc.com.
๐Ÿ‘๏ธ0
rich pearl rich pearl 7 years ago
i was doing a little browsing and noticed EMBT had an 8k on July 12th.

what's with this stock? i have a small position tucked inside my 'Tomorrow' drawer, and i'm wondering if i should lock it instead inside a time capsule. its come down to .25 x .35, and the minimalist 2500 shares offered was bought, but i notice that didn't take out the ask. obviously they're still doing business (of a sort,) but the stock itself has either gone into hibernation mode, or is inert.

i'm trying to patiently wait this one out, but i'm feeling rather poorly at the moment.

::sigh:

rich


*******************

On May 19, 2017, Ember Therapeutics, Inc. (โ€œEmber Therapeuticsโ€) entered into a Contribution Agreement (โ€œDermaSilk Agreementโ€) with DermaSilk Brands, Inc. (โ€œDermaSilkโ€), a Delaware corporation. Pursuant to the DermaSilk Agreement, DermaSilk acquired the sole ownership interest in DermaSilk Brands business, including all assets and liabilities related thereto, and DermaSilk became a wholly owned subsidiary of Ember Therapeutics. The DermaSilk Agreement isa ttached as Exhibit 99.1.

Also on May 19, 2017, Ember Therapeutics entered into a Contribution Agreement (โ€œMigralex Agreementโ€) with Migralex, Inc. (โ€œMigralexโ€) a Delaware corporation. Pursuant to the Migralex Agreement, Migralex acquired the sole ownership interest in the Migralex business, including all assets and liabilities related thereto, and Migralex became a wholly owned subsidiary of Ember Therapeutics. The MigralexAgreement is attached as Exhibit 99.1.

************
๐Ÿ‘๏ธ0
$hellKing $hellKing 7 years ago
Guess the headache meds didnt get renewed by CVS? The last bottle I bought was expired by a few months and I havent noticed it the last few locations Ive gone to.
๐Ÿ‘๏ธ0
$hellKing $hellKing 8 years ago
EMBT my biggest disappointment 2016. What in the world happened with these guys? lowest damn float Prior NASDAQ CEO and he lets it go dark????? Totally sucks here. Was hoping this would be 3 to 5 bucks.....
๐Ÿ‘๏ธ0
$hellKing $hellKing 8 years ago
Disappointed this hasnt gotten higher. Heck they cant even get filings right for their 2 stocks. How were they going to operate a NASDAQ big board if they cant even get the filings right for MICB and EMBT? I totally read this dude wrong... CEO is going to get his MICB revoked if he doesnt get those filings out....
๐Ÿ‘๏ธ0
TheInvincibleBull TheInvincibleBull 8 years ago
$EMBT news baby!!!
๐Ÿ‘๏ธ0
adijas adijas 8 years ago
8k out.

Item 1.01 Entry Into A Material Definitive Agreement

On September 8, 2016, we entered into an Asset Purchase Agreement (the "Agreement") with Midwood Distributors, Inc., a New York corporation ( "Midwood Distributors"). Under the Agreement, we acquired all assets related to Dermasilk Brands, a line of anti-aging skin care products.

Under the Agreement, we have acquired all material assets currently owned by Dermasilk, including all inventory, raw materials, work in process, packaging, the toll free number, hardware and software used for ordering and customer support, all intellectual property, websites, domain names, accounts receivable and vendor credits, contracts, and all marketing and promotional information and materials.

The purchase price for the Dermasilk assets consisted of common stock and warrants, paid as follows:
โ€ข 2,105,263 shares of common stock at purchase price of $0.95.
๐Ÿ‘๏ธ0
TheInvincibleBull TheInvincibleBull 8 years ago
This baby is going to sky rocket
๐Ÿ‘๏ธ0
TheInvincibleBull TheInvincibleBull 8 years ago
Heck yes!! It's been a long wait
๐Ÿ‘๏ธ0
adijas adijas 8 years ago
NEWS!!

NEW YORK , Sept. 12, 2016 (GLOBE NEWSWIRE) -- Ember Therapeutics, Inc. (OTCQB:EMBT), a diversified New York -based pharmaceutical company developing targeted therapies for osteoarthritis, kidney fibrosis, and other regenerative medicines, today announced that it has entered into a definitive agreement for the acquisition of Dermasilkโ„ข Brands, a commercially available over-the-counter beauty product portfolio encompassing fourteen different products. The products are currently sold at several large retailers including Rite-Aid , CVS, Wal-Mart and K-Mart .
As part of the transaction, all assets from Dermasilk Brands, Inc. will be transferred to Ember Therapeutics, Inc.
โ€œThis is our third acquisition this year. The addition of the Dermasilkโ„ข brand of products to our product line will allow us to expand on our current relationship with major retailers and provide additional revenues to Ember. Dermasilk products have a large customer following and are developed using the highest cutting edge science,โ€ said Joseph Hernandez , Executive Chairman of Ember Therapeutics, Inc. โ€œThe revenues generated by these products and Migralexโ„ข, our other commercially available product, will help further the development of our two Phase 3 ready clinical programs in osteoarthritis and regenerative medicine.โ€

Dermasilkโ„ข products are currently available at Rite-Aid , CVS, Wal-Mart , K-Mart , local pharmacies, and online at jet.com and the product website www.dermasilkbrands.com. To learn more about Dermasilkโ„ข please access www.dermasilkbrands.com.
About Ember Therapeutics, Inc.

Ember Therapeutics, Inc. is a diversified pharmaceutical company commercializing and developing targeted therapies for pain, osteoarthritis, kidney fibrosis and other regenerative medicines. In particular, Ember Therapeutics, Inc. has a commercial stage pain product and two late stage Phase 3 ready assets. For more information, please visit www.embertx.com.
๐Ÿ‘๏ธ0
TheInvincibleBull TheInvincibleBull 8 years ago
$EMBT $1 :)
๐Ÿ‘๏ธ0
adijas adijas 8 years ago
SEC filings coming soon! http://www.embertx.com/sec.html
๐Ÿ‘๏ธ0
TheInvincibleBull TheInvincibleBull 8 years ago
$1 up $EMBT
๐Ÿ‘๏ธ0
TheInvincibleBull TheInvincibleBull 8 years ago
Good Morning!!! $EMBT
๐Ÿ‘๏ธ0
TheInvincibleBull TheInvincibleBull 8 years ago
.73x.90 bids coming in
๐Ÿ‘๏ธ0
TheInvincibleBull TheInvincibleBull 8 years ago
Good Morning $EMBT. Let's see if we can close near the high of the week
๐Ÿ‘๏ธ0
TheInvincibleBull TheInvincibleBull 8 years ago
.90,$1.3, then $4
๐Ÿ‘๏ธ0
TheInvincibleBull TheInvincibleBull 8 years ago
.90 up
๐Ÿ‘๏ธ0
TheInvincibleBull TheInvincibleBull 8 years ago
Gonna add another 650 sometime this week. All these small adds I am starting to have a very nice size position here :)
๐Ÿ‘๏ธ0
TheInvincibleBull TheInvincibleBull 8 years ago
$7,000 bid someone trying to load a nice chunk here
๐Ÿ‘๏ธ0
TheInvincibleBull TheInvincibleBull 8 years ago
Huge bid in at .70 time for us to go back well over a $1. Us longs have been accumulating as many as we can. $EMBT working with Knight is huge $$$
๐Ÿ‘๏ธ0
adijas adijas 8 years ago
bid raised to .7
๐Ÿ‘๏ธ0
adijas adijas 8 years ago
10k bid at .65
๐Ÿ‘๏ธ0
$hellKing $hellKing 8 years ago
I was saying it from beginning that this had 5.00+ written all over it. I think it still does for sure. I would even try to sneak in 1.50s of MICB too. someone had 2k for sale there the other day. But 1.00 would be better. Both these stocks are poised for major moves.
๐Ÿ‘๏ธ0
TheInvincibleBull TheInvincibleBull 8 years ago
$EMBT slapping the ask time. Getting this well over a $1
๐Ÿ‘๏ธ0
TheInvincibleBull TheInvincibleBull 8 years ago
.75x$1.00 and the ask is thin. Thinking we got any new short term flippers that came in Friday out. We don't want flippers. We want longs to get this to the proper price. At least $5+ imo $EMBT
๐Ÿ‘๏ธ0
TheInvincibleBull TheInvincibleBull 8 years ago
When you have a $1Billion plus company(Knight Therapeutics Inc) you don't need hope lol. This isn't a stinky pinky. Billion dollar company's only work with legit companies. $EMBT my favorite sleeping gem
๐Ÿ‘๏ธ0
retireat40 retireat40 8 years ago
Not true I just try to be realistic and not pump every stock I touch.
๐Ÿ‘๏ธ0
$hellKing $hellKing 8 years ago
We prob need to DD the other acquisitions as well just to see the potential value of those acquisitions and what they were for. Most of those biotech brains know what they are looking at. Im still a beginner with those things.


Like MICB made a deal with this other OTC. they were going to use that particular cos delivery system for their patents.


But heck EMBT has over 400 patents. Im not sure how many patents usual biotechs have but 400 sounds like A LOT!


๐Ÿ‘๏ธ0
TheInvincibleBull TheInvincibleBull 8 years ago
Nope not hoping at all. Every chance I get I add. Spend 5 mins doing dd and you know you don't have to hope. Love this company. See this is why I asked why you are here. Such a negative person. All the time on every stock.
๐Ÿ‘๏ธ0
retireat40 retireat40 8 years ago
Gotcha. Hold and hope lol
๐Ÿ‘๏ธ0
TheInvincibleBull TheInvincibleBull 8 years ago
Long term play. Been here awhile accumulating and holding for the gold
๐Ÿ‘๏ธ0
retireat40 retireat40 8 years ago
Need some buyers here...
๐Ÿ‘๏ธ0
TheInvincibleBull TheInvincibleBull 8 years ago
Yep, a very strong chance imo
๐Ÿ‘๏ธ0
TheInvincibleBull TheInvincibleBull 8 years ago
Yep $EMBT loving it
๐Ÿ‘๏ธ0
$hellKing $hellKing 8 years ago
Its ok. We will prob be 1.50 then 2.00 soon enough. This is one of my fav otc right now. It will all be done regardless and be done legit too.
๐Ÿ‘๏ธ0
retireat40 retireat40 8 years ago
I think this actually has ATH* possibilities. That ran from this range to $10.
๐Ÿ‘๏ธ0
retireat40 retireat40 8 years ago
Contrary to what some idiots may think, I do own shares here (wouldn't touch that BK POS though). I was simply stating that I had hoped for a little more volume after the nice pop on Friday. People are far too sensitive.
๐Ÿ‘๏ธ0
retireat40 retireat40 8 years ago
Huh? What's your problem?
๐Ÿ‘๏ธ0
TheInvincibleBull TheInvincibleBull 8 years ago
I got another 700 shares yet again today ;)
๐Ÿ‘๏ธ0
TheInvincibleBull TheInvincibleBull 8 years ago
Why are you here
๐Ÿ‘๏ธ0
retireat40 retireat40 8 years ago
.65 x 1.02 Thought it might take off today. Guess not.
๐Ÿ‘๏ธ0
TheInvincibleBull TheInvincibleBull 8 years ago
$1.25 let's go!!!!
๐Ÿ‘๏ธ0
TheInvincibleBull TheInvincibleBull 8 years ago
Only 610 left at $1.25
๐Ÿ‘๏ธ0
$hellKing $hellKing 8 years ago
I think the trading float is 10% of the actual float. Only a few shares were dropped initially. probably some ancient holder that had no idea what was going on. Now this is top of the line RM. You know they are going to put the Migralex thing out on some mailers or something in the future that will make this go to several dollars.



They are going to be making more and more deals as well. This will be huge soon
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock